BIOMAT Database Logo BIOMAT Database Logo

Evolving concepts in systemic lupus erythematosus damage assessment. 2021

Megan R W Barber, and Sindhu R Johnson, and Dafna D Gladman, and Ann E Clarke, and Ian N Bruce
Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D009102 Multiple Organ Failure A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative. MODS,Multiple Organ Dysfunction Syndrome,Organ Dysfunction Syndrome, Multiple,Organ Failure, Multiple,Failure, Multiple Organ,Multiple Organ Failures
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D012107 Research Design A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly. Experimental Design,Data Adjustment,Data Reporting,Design, Experimental,Designs, Experimental,Error Sources,Experimental Designs,Matched Groups,Methodology, Research,Problem Formulation,Research Methodology,Research Proposal,Research Strategy,Research Technics,Research Techniques,Scoring Methods,Adjustment, Data,Adjustments, Data,Data Adjustments,Design, Research,Designs, Research,Error Source,Formulation, Problem,Formulations, Problem,Group, Matched,Groups, Matched,Matched Group,Method, Scoring,Methods, Scoring,Problem Formulations,Proposal, Research,Proposals, Research,Reporting, Data,Research Designs,Research Proposals,Research Strategies,Research Technic,Research Technique,Scoring Method,Source, Error,Sources, Error,Strategies, Research,Strategy, Research,Technic, Research,Technics, Research,Technique, Research,Techniques, Research
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D013995 Time The dimension of the physical universe which, at a given place, orders the sequence of events. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Effects, Long-Term,Effects, Longterm,Long-Term Effects,Longterm Effects,Effect, Long-Term,Effect, Longterm,Effects, Long Term,Long Term Effects,Long-Term Effect,Longterm Effect
D017281 Cost of Illness The personal cost of disease which may be economic, social, or psychological. The cost of illness may be reflected in absenteeism, productivity, response to treatment, peace of mind, or QUALITY OF LIFE. It differs from HEALTH CARE COSTS, the societal cost of providing services related to the delivery of health care. Burden Of Disease,Burden of Illness,Disease Burden,Disease Costs,Cost of Disease,Cost of Sickness,Costs of Disease,Disease Cost,Economic Burden of Disease,Sickness Cost,Burden Of Diseases,Burden, Disease,Cost, Disease,Disease Burdens,Illness Burden,Illness Burdens,Illness Cost,Illness Costs,Sickness Costs
D064420 Drug-Related Side Effects and Adverse Reactions Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals. Drug-Related Side Effects and Adverse Reaction,Adverse Drug Event,Adverse Drug Reaction,Drug Side Effects,Drug Toxicity,Side Effects of Drugs,Toxicity, Drug,Adverse Drug Events,Adverse Drug Reactions,Drug Event, Adverse,Drug Events, Adverse,Drug Reaction, Adverse,Drug Reactions, Adverse,Drug Related Side Effects and Adverse Reaction,Drug Related Side Effects and Adverse Reactions,Drug Side Effect,Drug Toxicities,Effects, Drug Side,Reactions, Adverse Drug,Side Effect, Drug,Side Effects, Drug,Toxicities, Drug

Related Publications

Megan R W Barber, and Sindhu R Johnson, and Dafna D Gladman, and Ann E Clarke, and Ian N Bruce
Evolving Concepts in Systemic Lupus Erythematosus.
December 2016, The Israel Medical Association journal : IMAJ,
Megan R W Barber, and Sindhu R Johnson, and Dafna D Gladman, and Ann E Clarke, and Ian N Bruce
NIH conference. Systemic lupus erythematosus: evolving concepts.
October 1979, Annals of internal medicine,
Megan R W Barber, and Sindhu R Johnson, and Dafna D Gladman, and Ann E Clarke, and Ian N Bruce
[Subacute lupus erythematosus evolving to systemic lupus erythematosus during pregnancy].
December 1998, Anales de medicina interna (Madrid, Spain : 1984),
Megan R W Barber, and Sindhu R Johnson, and Dafna D Gladman, and Ann E Clarke, and Ian N Bruce
Assessment of damage in Korean patients with systemic lupus erythematosus.
May 2007, The Journal of rheumatology,
Megan R W Barber, and Sindhu R Johnson, and Dafna D Gladman, and Ann E Clarke, and Ian N Bruce
Changing concepts of systemic lupus erythematosus.
January 1978, Comprehensive therapy,
Megan R W Barber, and Sindhu R Johnson, and Dafna D Gladman, and Ann E Clarke, and Ian N Bruce
Systemic lupus erythematosus evolving into rheumatoid arthritis.
January 2006, The Journal of rheumatology,
Megan R W Barber, and Sindhu R Johnson, and Dafna D Gladman, and Ann E Clarke, and Ian N Bruce
Vascular damage in systemic lupus erythematosus.
April 2024, Nature reviews. Nephrology,
Megan R W Barber, and Sindhu R Johnson, and Dafna D Gladman, and Ann E Clarke, and Ian N Bruce
Evolving story of autoantibodies in systemic lupus erythematosus.
June 2020, Journal of autoimmunity,
Megan R W Barber, and Sindhu R Johnson, and Dafna D Gladman, and Ann E Clarke, and Ian N Bruce
Hyperkeratotic nail discoid lupus erythematosus evolving towards systemic lupus erythematosus: therapeutic difficulties.
November 2004, Journal of the European Academy of Dermatology and Venereology : JEADV,
Megan R W Barber, and Sindhu R Johnson, and Dafna D Gladman, and Ann E Clarke, and Ian N Bruce
Changing concepts of acute systemic lupus erythematosus.
October 1954, The Journal of the Tennessee State Medical Association. Tennessee State Medical Association,
Copied contents to your clipboard!